Chronic Hepatitis B — New Goals, New Treatment

摘要: The hepatitis B virus (HBV) causes chronic infection in approximately 400 million people the world. Most carriers of HBV, including Asians, Africans, and a proportion persons Mediterranean countries, acquire at birth or within first 1 to 2 years after birth.1 It is estimated that 50% male 14% female will eventually die complications cirrhosis hepatocellular carcinoma.2 criteria end points for treatment HBV should be reevaluated light three important recent findings. First, more than 70% patients with . . .